Weight Loss Continues Five Years After Tummy Tucks
THURSDAY, July 3, 2025 -- Patients undergoing abdominoplasty experience continued weight loss up to five years postoperatively, according to a study published in the July issue of Plastic and Reconstructive Surgery.
Jonathan Bricker, M.D., from Northwestern Memorial Hospital in Chicago, and colleagues quantified continued weight loss after abdominoplasty procedures. The analysis included 188 patients with an average follow-up of 26.5 months.
The researchers found that the average preoperative weight was 167.8 lb, and the average body mass index was 27.7 kg/m2. Average weight loss continued to decline over time (with percentage of body weight following surgery) and was −5.77 lb (−3.15 percent) at three months, −5.28 lb (−2.77 percent) at six months, −4.02 lb (−2.17 percent) at 12 months, −4.18 lb (−2.23 percent) at two years, −4.16 lb (−2.20 percent) at three years, and −9.8 lb (−5.29 percent) at five years. No patient who lost weight required revision surgery for additional skin removal.
"We have found that patients who were able to achieve weight loss after their abdominoplasty succeeded in developing healthy habits that centered around nutrition and exercise," senior author John Y.S. Kim, M.D., from Northwestern University Feinberg School of Medicine in Chicago, said in a statement.
One author is a patent and equity holder for Surgical Innovation Associates and EDGe Surgical.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Read this next
Oral Orforglipron Yields Greater Weight Reductions Than Placebo
THURSDAY, Sept. 25, 2025 -- For adults with obesity who do not have diabetes, the oral glucagon-like peptide-1 receptor agonist orforglipron yields significantly greater...
Oral Semaglutide Effective for Weight Loss in Overweight or Obesity
THURSDAY, Sept. 25, 2025 -- Oral semaglutide (25 mg) is effective for weight loss in adults with overweight or obesity without diabetes, according to a study published online...
GLP-1 Receptor Agonists Improve Glycemic, Weight Outcomes in Children With T2D
TUESDAY, Sept. 23, 2025 -- In children and adolescents with type 2 diabetes (T2D) or obesity, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) improve glycemic, weight, and...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.